Smiths Group announced the sale of 1.2 million shares in ICU Medical on Wednesday, amounting to roughly 4.9% of ICU Medical’s issued share capital.
Source: Sharecast
The FTSE 100 company said the transaction was set to generate net proceeds of approximately $152m (£117m) for the group.
It said it planned to use the funds for general corporate purposes.
After the sale, Smiths Group retained a stake in ICU Medical, holding 0.47 million shares, equating to around 1.92% of ICU’s issued share capital.
At 0828 BST, shares in Smiths Group were down 0.29% at 1,746p.
Reporting by Josh White for Sharecast.com.
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.